C-Path launches drug repurposing platform

By The Science Advisory Board staff writers

June 24, 2020 -- Critical Path Institute (C-Path) has launched a drug repurposing platform to accelerate the identification of new uses of existing drugs to treat infections, including COVID-19.

C-Path launched the Cure Drug Repurposing Collaboratory to speed up the development of potentially effective drugs for patients with diseases that lack adequate approved treatment options. The goal is to identify drug candidates for future clinical trials and for potential drug labeling in the future.

The program will capture relevant real-world clinical outcome data through the Cure ID platform. Institutions, researchers, private practitioners, government facilities, and healthcare professionals around the world can report novel uses of existing drugs by visiting C-Path's site or downloading the Cure ID mobile app.

The platform was funded with approximately $1.1 million from the U.S. Food and Drug Administration in collaboration with the National Institutes of Health's National Center for Advancing Translational Sciences.

Repurpose.AI, Scripps collaborate on COVID-19 drug discovery
Repurpose.AI will collaborate with Scripps Research to develop COVID-19 therapeutics with a focus on drug repurposing.
Frontier to produce RBT-9 for COVID-19 clinical trial
Frontier Scientific is collaborating with Renibus Therapeutics to develop a COVID-19 therapeutic drug.
Ampio begins COVID-19 phase I clinical trial for immunotherapy
Ampio Pharmaceuticals will begin a phase I clinical trial to evaluate its Ampion drug candidate for treatment of COVID-19 patients who are on supplemental...
Yumab spinoff Corat to develop COVID-19 drug
Yumab has announced that the first financing round of its spinoff Corat Therapeutics will be used to advance the development of COVID-19 antibody drug...
Accelerating COVID-19 drug repurposing with computers, organ chips
The U.S. Defense Advanced Research Projects Agency (DARPA) has awarded the Wyss Institute for Biologically Inspired Engineering at Harvard University...

Copyright © 2020 scienceboard.net

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter